查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032426

產前和新生兒基因檢測市場報告：按產品類型、篩檢、疾病、最終用戶和地區分類（2026-2034 年）

Prenatal and Newborn Genetic Testing Market Report by Product Type, Screening, Disease, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球產前和新生兒基因檢測市場規模達75億美元。展望未來，IMARC Group預測，該市場從2026年到2034年將以10.17%的複合年成長率成長，到2034年達到183億美元。市場佔有率的穩定成長主要得益於對先進診斷和篩檢設備需求的不斷成長、醫療保健行業的蓬勃發展以及新生兒先天性畸形和基因異常患病率的上升。

產前和新生兒基因檢測市場趨勢：

嬰兒遺傳疾病高發生

子宮內的胎兒易患多種遺傳疾病。這些遺傳疾病的遺傳方式在決定疾病復發的可能性以及孕期風險方面起著至關重要的作用。如果父母有染色體異常、有遺傳疾病家族病史或兄弟姐妹已患有遺傳疾病，那麼嬰兒患遺傳疾病的可能性就會增加。嬰兒罹患遺傳疾病的幾率顯著高於其他族群。此外，這些疾病是全球嬰兒死亡的主要原因之一。例如，根據世界衛生組織（WHO）估計，全球每年有790萬個嬰兒出生時患有遺傳異常。因此，嬰兒遺傳疾病的高發生率推動了產前和新生兒基因檢測市場的發展前景。

技術進步

產前和新生兒基因檢測市場的成長主要由技術進步所驅動。許多重大技術進步，例如非侵入性產前檢測和次世代定序，在確保提高準確性和治療效果的安全標準下，顯著提升了篩檢流程的品質。此外，醫療產業大力推廣使用這些創新技術來檢測和識別更廣泛的基因異常。這有助於準媽媽及其伴侶為未出生孩子的健康和安全做出最佳選擇。技術的顯著進步也提高了檢測結果的可靠性和確定性。

意識提高和需求成長

由於人們意識的提高和需求的成長，產前和新生兒基因檢測市場正經歷著快速發展。近年來，包括孕婦和醫療保健專業人員在內的越來越多的人認知到早期基因篩檢的價值。這促使市場對創新技術的需求日益成長。利用這些創新技術，我們可以了解現有的基因異常，以便及時採取預防措施，降低胎兒生命風險。準父母可以就未出生孩子的健康和安全做出最佳決策。為了因應這一日益成長的需求，全球的研究人員和投資者正將目光聚焦於這些檢測服務。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球產前與新生兒基因檢測市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 消耗品
  • 裝置

第7章 市場區隔：依篩檢方法

  • 非侵入性產前檢測
  • 絨毛膜絨毛取樣
  • 羊膜穿刺術
  • 母體血清篩檢

第8章 市場區隔：依疾病分類

  • 唐氏症
  • 苯酮尿症
  • 囊腫纖維化
  • 鐮狀細胞貧血症

第9章 市場區隔：依最終用戶分類

  • 醫院
  • 婦產科和專科診所
  • 診斷中心

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章：促進、抑制與機遇

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • BGI Group
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Laboratory Corporation of America Holdings
    • Natera Inc.
    • PerkinElmer Inc.
    • Quest Diagnostics Incorporated
    • Ravgen Inc.
Product Code: SR112026A11196

The global prenatal and newborn genetic testing market size reached USD 7.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 18.3 Billion by 2034, exhibiting a growth rate (CAGR) of 10.17% during 2026-2034. The market share is experiencing steady growth driven by the growing demand for advanced diagnostic and screening devices, the thriving medical industry, and the rising prevalence of congenital malformations and genetic abnormalities in newborn babies.

Prenatal and Newborn Genetic Testing Market Analysis:

  • Major Market Drivers: The increasing demand for prenatal and newborn genetic testing and a growing medical industry are driving the prenatal and newborn genetic testing market growth.
  • Key Market Trends: Key trends include increasing adoption of genetic testing for personalized medicine in prenatal and newborn care. This is positively impacting the prenatal and newborn genetic testing market trends.
  • Geographical Trends: North America leads the prenatal and newborn genetic testing market demand due to the growing number of pregnant women undergoing genetic screening. The prenatal and newborn genetic testing market forecast for Asia Pacific is also expected to witness growth.
  • Competitive Landscape: Abbott Laboratories and BGI Group are some of the prenatal and newborn genetic testing market companies driving the prenatal and newborn genetic testing market revenue.
  • Challenges and Opportunities: Challenges include ethical and legal considerations. The prenatal and newborn genetic testing market recent opportunities lie in the integration of AI and ML technologies.

Prenatal and Newborn Genetic Testing Market Trends:

High Prevalence of Genetic Diseases in Infants

The fetuses in the womb are affected by several genetic disorders. The inheritance pattern of these genetic illnesses has a role in determining both the chance of recurrence and the risk they pose during pregnancy. Babies that have a parent with a chromosomal anomaly, a family history of genetic disorders, or another kid who has a genetic disease are more likely to have genetic diseases. Infants are significantly more likely to be affected by hereditary disorders. Furthermore, these illnesses are to blame for infant mortality worldwide. For example, the World Health Organization predicted that 7.9 million babies worldwide are born with genetic abnormalities. Therefore, the high prevalence of genetic diseases in infants is driving the prenatal and newborn genetic testing market outlook.

Technological advancements

The growth of the prenatal and newborn genetic testing market report is mostly due to advancements in technology. A number of significant advancements, such as non-invasive prenatal testing and next-generation sequencing, have improved the quality of the screening procedure while maintaining safety requirements that guarantee accuracy and improved outcomes. Furthermore, it is highly recommended that the healthcare industry use these innovations to detect and identify a larger range of genetic abnormalities. It also makes sure that the expectant parents decide what's best for the health and safety of their unborn child. Furthermore, a significant improvement has been made, which raises the transformations' authenticity and dependability.

Increasing awareness and demand

The prenatal and newborn genetic testing market overview has experienced an incredible expansion due to the growing awareness and demand for prenatal and newborn genetic testing. These days, the value of early genetic screening is being recognized by more people, including expectant parents and healthcare professionals. The market's need for innovation has increased as a result of this. By using this innovation, a person can learn about genetic abnormalities that are still present and take timely preventative action to reduce the risk to the lives of the babies. With regard to the health and safety of their unborn child, pregnant parents are capable of making the best decisions. Researchers and investors from all over the world have been drawn to the testing services due to their increasing demand.

Prenatal and Newborn Genetic Testing Industry Segmentation:

Breakup by Product Type:

  • Consumables
  • Instruments

Consumables account for the majority of the market share

Consumables like testing kits and reagents are fueling the prenatal and newborn genetic testing market recent developments. These kits are really important for checking if babies have any genetic problems before they're born or right after they're born. Also, new technology is making these tests better and easier to do. As more people want these tests, the market for the supplies needed for them is growing, too. Doctors need these supplies to offer good genetic testing services. So, these supplies are a big part of why prenatal and newborn genetic testing is becoming more popular and helpful for families.

Breakup by Screening:

  • Non-invasive Prenatal Testing
  • Chorionic Villus Sampling
  • Amniocentesis
  • Maternal Serum Screening

Non-invasive prenatal testing holds the largest share of the industry

NIPT is the best way to check babies before they're born. It doesn't require taking samples from the womb. It depends on simple blood tests from the mother. This method is safer and more comfortable. It offers accurate results in detecting genetic conditions like Down syndrome. It doesn't involve any complications associated with invasive techniques. Due to these benefits, more expecting parents are opting for NIPT. It's the top choice for prenatal testing as it's convenient, safe, and gives reliable results.

Breakup by Disease:

  • Downs Syndrome
  • Phenylketonuria
  • Cystic Fibrosis
  • Sickle Cell Anemia

Downs syndrome represents the leading market segment

The largest prenatal and newborn genetic testing market recent price is held by Down syndrome testing. An additional copy of chromosome 21 causes this disorder. It is essential for aspiring parents to get tested for Down syndrome in order to plan for any particular care their child may require. The accuracy and accessibility of Down syndrome diagnostics have increased due to technological breakthroughs. Pregnant women are choosing these tests more frequently in order to protect the health of their unborn child. Furthermore, these examinations are advised by medical professionals as standard prenatal care. There is a large demand for testing, which has led to its dominance in the genetic testing market.

Breakup by End User:

  • Hospital
  • Maternity and Specialty Clinics
  • Diagnostic Centers

Hospital represents the leading market segment

Hospitals are at the top of the market. They are essential in the provision of many medical services, such as genetic testing. Patients seeking genetic testing services prefer hospitals as they are dependable and convenient. Hospitals provide accurate testing and appropriate counselling for patients and their families since they have highly qualified staff and modern facilities. Hospitals also frequently work with medical specialists to provide proper care. People are drawn to hospitals due to their reputation for providing high-quality healthcare services. They thereby lead the market share, confirming their status as the main suppliers of genetic testing services.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest prenatal and newborn genetic testing market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

With a sizable portion of the global market for prenatal and newborn genetic testing, North America currently has a prominent position. The prenatal and newborn genetic testing market has strengthened its position in the region due to a significant number of companies operating in the diagnostics and screening sectors, in addition to the region's increased prevalence of genetic abnormalities and a huge pool of highly aware parents. Also, an increasing number of expecting mothers in this area are having their genetics screened, which supports the market's expansion. The strong purchasing power and growing public knowledge are anticipated to fuel market expansion. For example, March 21st is designated as World Down Syndrome Day each year to raise awareness of the diagnosis and care of individuals with Down syndrome.

Leading Key Players in the Prenatal and Newborn Genetic Testing Industry:

The market for prenatal and newborn genetic testing is expanding rapidly due to the major companies' creativity, innovation, teamwork, and cutting-edge technology. Some of the biggest businesses are constantly working to improve the testing process's quality and safety. The key players are primarily concerned with growing the test panels' capacity to screen for and identify genetic diseases. Additionally, the market for prenatal and newborn genetic testing is expanding at an even faster rate with the help of technological advancements. Furthermore, accessibility and flexibility are guaranteed through partnerships with regulatory bodies and the healthcare industry. Both the expecting parents and their newborns greatly benefit from prenatal and newborn genetic testing.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • BGI Group
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche AG
  • Illumina Inc.
  • Laboratory Corporation of America Holdings
  • Natera Inc.
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • Ravgen Inc.

Key Questions Answered in This Report:

  • How has the global prenatal and newborn genetic testing market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global prenatal and newborn genetic testing market?
  • What is the impact of each driver, restraint, and opportunity on the global prenatal and newborn genetic testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the screening?
  • Which is the most attractive screening in the prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the disease?
  • Which is the most attractive disease in the prenatal and newborn genetic testing market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the prenatal and newborn genetic testing market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global prenatal and newborn genetic testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Prenatal and Newborn Genetic Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Screening

  • 7.1 Non-invasive Prenatal Testing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chorionic Villus Sampling
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Amniocentesis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Maternal Serum Screening
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Downs Syndrome
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Phenylketonuria
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cystic Fibrosis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Sickle Cell Anemia
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospital
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Maternity and Specialty Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diagnostic Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 BGI Group
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bio-Rad Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Illumina Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Laboratory Corporation of America Holdings
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Natera Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 PerkinElmer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Quest Diagnostics Incorporated
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Ravgen Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Prenatal and Newborn Genetic Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Prenatal and Newborn Genetic Testing Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Product Type (in %), 2025
  • Figure 5: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Screening (in %), 2025
  • Figure 6: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Disease (in %), 2025
  • Figure 7: Global: Prenatal and Newborn Genetic Testing Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Prenatal and Newborn Genetic Testing Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Prenatal and Newborn Genetic Testing (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Prenatal and Newborn Genetic Testing (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Prenatal and Newborn Genetic Testing (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Prenatal and Newborn Genetic Testing (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Prenatal and Newborn Genetic Testing (Non-invasive Prenatal Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Prenatal and Newborn Genetic Testing (Non-invasive Prenatal Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Prenatal and Newborn Genetic Testing (Chorionic Villus Sampling) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Prenatal and Newborn Genetic Testing (Chorionic Villus Sampling) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Prenatal and Newborn Genetic Testing (Amniocentesis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Prenatal and Newborn Genetic Testing (Amniocentesis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Prenatal and Newborn Genetic Testing (Maternal Serum Screening) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Prenatal and Newborn Genetic Testing (Maternal Serum Screening) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Prenatal and Newborn Genetic Testing (Downs Syndrome) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Prenatal and Newborn Genetic Testing (Downs Syndrome) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Prenatal and Newborn Genetic Testing (Phenylketonuria) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Prenatal and Newborn Genetic Testing (Phenylketonuria) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Prenatal and Newborn Genetic Testing (Cystic Fibrosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Prenatal and Newborn Genetic Testing (Cystic Fibrosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Prenatal and Newborn Genetic Testing (Sickle Cell Anemia) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Prenatal and Newborn Genetic Testing (Sickle Cell Anemia) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Prenatal and Newborn Genetic Testing (Hospital) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Prenatal and Newborn Genetic Testing (Hospital) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Prenatal and Newborn Genetic Testing (Maternity and Specialty Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Prenatal and Newborn Genetic Testing (Maternity and Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Prenatal and Newborn Genetic Testing (Diagnostic Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Prenatal and Newborn Genetic Testing (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: North America: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: North America: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: United States: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: United States: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Canada: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Canada: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Asia-Pacific: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Asia-Pacific: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: China: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: China: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Japan: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Japan: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: India: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: India: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: South Korea: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: South Korea: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Australia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Australia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Indonesia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Indonesia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Europe: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Europe: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Germany: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Germany: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: France: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: France: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: United Kingdom: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: United Kingdom: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Italy: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Italy: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Spain: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Spain: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Russia: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Russia: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Latin America: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Latin America: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Brazil: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Brazil: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Mexico: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Mexico: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Others: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Others: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Middle East and Africa: Prenatal and Newborn Genetic Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Middle East and Africa: Prenatal and Newborn Genetic Testing Market: Breakup by Country (in %), 2025
  • Figure 83: Middle East and Africa: Prenatal and Newborn Genetic Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Global: Prenatal and Newborn Genetic Testing Industry: Drivers, Restraints, and Opportunities
  • Figure 85: Global: Prenatal and Newborn Genetic Testing Industry: Value Chain Analysis
  • Figure 86: Global: Prenatal and Newborn Genetic Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Prenatal and Newborn Genetic Testing Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Screening (in Million USD), 2026-2034
  • Table 4: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Disease (in Million USD), 2026-2034
  • Table 5: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Prenatal and Newborn Genetic Testing Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Prenatal and Newborn Genetic Testing Market: Competitive Structure
  • Table 8: Global: Prenatal and Newborn Genetic Testing Market: Key Players